GSK-2556286

N/A

Report date: 2025/05/15 20:00:08

NME

Base Information

Drug NameGSK-2556286

Drug Alias NameGSK-2556286GSK-286

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMycobacterium tuberculosis inhibitorsFAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase inhibitors

TargetsFAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase

Therapy Area/IndicationsTuberculosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlandsUnited Kingdom

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsTuberculosis

ATC CodeN/A